3SBio Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TRSBF research report →
About the company
3SBio Inc. is a China-based investment holding company deeply engaged in the biopharmaceutical sector, encompassing the entire value chain from research and development to manufacturing, marketing, and sales of its innovative products. The company's extensive biopharmaceutical portfolio caters to a wide array of therapeutic needs.
- CEO
- Jing Lou
- IPO
- 2018
- Employees
- 5,577
- HQ
- Shenyang, CN
Price Chart
- Market Cap
- $5.38B
- P/E
- 4.98
- P/S
- 2.39
- P/B
- 1.55
- EV/EBITDA
- 2.97
- Div Yield
- 1.28%
- Gross Margin
- 92.38%
- Op Margin
- 59.59%
- Net Margin
- 47.93%
- ROE
- 38.96%
- ROIC
- 26.48%
- Revenue
- $17.24B · 89.27%
- Net Income
- $8.26B · 295.31%
- EPS
- $3.43 · 298.84%
- Op Income
- $10.29B
- FCF YoY
- 307.84%
- 52W High
- $4.74
- 52W Low
- $2.00
- 50D MA
- $2.48
- 200D MA
- $3.08
- Beta
- 0.47
- Avg Volume
- 779
Get TickerSpark's AI analysis on TRSBF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our TRSBF coverage
Recent articles, reports, and earnings notes.
No research on TRSBF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TRSBF report →Similar companies
Peers in the same neighborhood.